Iranian Heart Journal

Iranian Heart Journal

Evaluation of Risk Factors Associated With Mortality in Patients Undergoing Primary PCI: A Retrospective Cohort Study

Document Type : Original Article

Authors
1 Department of Cardiology, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, IR Iran.
2 Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran.
Abstract
Background: This study investigates the prognosis and complications in patients who underwent primary percutaneous coronary intervention (PCI) at Rasul Akram Hospital between 2020 and 2021. The primary objective is to improve care quality for myocardial infarction (MI) patients post-PCI by identifying and analyzing prognostic factors. Given MI’s significant impact on mortality in industrialized and developing nations, recognizing and managing risk factors effectively can reduce disease burden.
 
Methods: A retrospective cohort design was employed. Patients were selected based on predefined inclusion and exclusion criteria. Demographic, clinical, and laboratory data and clinical outcomes were extracted from medical records and analyzed using SPSS software.
 
Results: Several factors influenced patient prognosis, including age, sex, prior heart disease, hypertension, diabetes, and hyperlipidemia. Those with a history of cardiac conditions or metabolic risk factors exhibited worse outcomes. The study also highlighted that timely PCI intervention and optimized risk factor management could enhance prognosis.
 
Conclusions: Early identification of high-risk patients and prompt, effective treatment are critical. Public and patient education on MI symptoms and the urgency of seeking immediate medical care may reduce treatment delays and improve outcomes. (Iranian Heart Journal 2025; 26(3): 6-14)
Keywords

  1. Pasotti M, Prati F, Arbustini E. The pathology of myocardial infarction in the pre-and post-interventional era. Heart. 2006; 92(11):1552-6.
  2. Amin A, Mohajerian A, Ghalehnoo SR, Mohamadinia M, Ahadi S, Sohbatzadeh T, et al. Potential Player of Platelet in the Pathogenesis of Cardiotoxicity: Molecular Insight and Future Perspective. Cardiovascular toxicology. 2024:1-14.
  3. Carrick D, Haig C, Rauhalammi S, Ahmed N, Mordi I, McEntegart M, et al. Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging. 2015; 8(7):779-89.
  4. Pahlm O, Haisty Jr WK, Wagner NB, Pope JE, Wagner GS. Specificity and sensitivity of QRS criteria for diagnosis of single and multiple myocardial infarcts. The American journal of cardiology. 1991; 68(13):1300-4.
  5. Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. European heart journal. 2014; 35(34):2303-11.
  6. Marzban M, Bahrami M, Kamalinejad M, Tahamtan M, Khavasi N, Haji M. The therapeutic effects of chicory seed aqueous extract on cardio-metabolic profile and liver enzymes in nonalcoholic fatty liver disease; a double blind randomized clinical trial. Immunopathologia Persa. 2022.
  7. Nazari SH, Azimi MR, Valinezhad S. White cheese physicochemical properties made of infra red pasteurized milk and aged in potassium chloride (KCL) substituted brine. 2017.
  8. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Evaluation. 1984; 2(3):4.
  9. Vafaie M. State-of-the-art diagnosis of myocardial infarction. Diagnosis. 2016; 3(4):137-42.
  10. Boeddinghaus J, Nestelberger T, Koechlin L, Wussler D, Lopez-Ayala P, Walter JE, et al. Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I. Journal of the American college of cardiology. 2020; 75(10):1111-24.
  11. Musavi H, Shokri-Afra H, Mahjoub S, Khonakdar-Tarsi A, Bagheri A, Memariani Z. Galbanic acid of Ferula assa-foetida L, as a regulator of the AMPK pathway in reduction of lipid accumulation in HepG2 cells. Immunopathol Persa. 2023.
  12. Hwang C, Levis JT. ECG diagnosis: ST-elevation myocardial infarction. The Permanente Journal. 2014; 18(2):e133.
  13. Vakili-Ojarood M, Naseri A, Shirinzadeh-Dastgiri A, Saberi A, HaghighiKian SM, Rahmani A, et al. Ethical considerations and equipoise in cancer surgery. Indian Journal of Surgical Oncology. 2024; 15(Suppl 3):363-73.
  14. Spitzer S, di Lego V, Kuhn M, Roth C, Berger R. Socioeconomic environment and survival in patients after ST-segment elevation myocardial infarction (STEMI): a longitudinal study for the City of Vienna. BMJ open. 2022; 12(7):e058698.
  15. Gharacholou SM, Lopes RD, Alexander KP, Mehta RH, Stebbins AL, Pieper KS, et al. Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial. Archives of internal medicine. 2011; 171(6):559-67.
  16. Stenestrand U, Lindbäck J, Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. Jama. 2006; 296(14):1749-56.
  17. Biswas S, Andrianopoulos N, Duffy SJ, Lefkovits J, Brennan A, Walton A, et al. Impact of socioeconomic status on clinical outcomes in patients with ST-segment–elevation myocardial infarction. Circulation: Cardiovascular Quality and Outcomes. 2019; 12(1):e004979.
  18. Vakili H, Sadeghi R, Rezapoor P, Gachkar L. In-hospital outcomes after primary percutaneous coronary intervention according to left ventricular ejection fraction. ARYA atherosclerosis. 2014; 10(4):211.
  19. Li Y, Lyu S. Risk factors of periprocedural bradycardia during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. Cardiology Research and Practice. 2019; 2019.
  20. Nikus K, Birnbaum Y, Fiol-Sala M, Rankinen J, de Luna AB. Conduction disorders in the setting of acute STEMI. Current Cardiology Reviews. 2021; 17(1):41-9.